EUVIMEDEUVIMED entdecken
Crossref

Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling

M Martin-Flores iD, A M Lorenzutti iD, L Pelligand iD

Journal of Small Animal Practice · 2026-11 · 67 (11) · 1071-1074

DOI: 10.1111/jsap.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Small Animal Practice, online erschienen am 24.05.2026. Verfasst von M Martin-Flores und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Metoclopramide, Antiemetics, Dog Diseases, Vomiting. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metoclopramide is used for prevention or treatment of emesis and gastroesophageal reflux in dogs. Historically, it has been administered three to four times a day. However, reports of adverse reactions associated with intravenous boluses raise concerns. A more modern trend is to administer the total daily dose as a constant rate infusion of 1 to 2 mg/kg/day. A loading dose prior to the infusion is often omitted, which can delay the onset of action. Adequate loading doses for these constant rate infusions are not known. We have reanalysed pharmacokinetic data from dogs receiving metoclopramide and modelled its behaviour when administered as a constant rate infusion, with and without loading doses. We have quantified the delay expected if loading doses are not administered and calculated appropriate loading doses designed to reach the target concentration while omitting unnecessarily high plasma levels. If a loading dose is omitted, a delay of 3.25 hours for reaching a steady state can be expected. Loading doses of 0.05 and 0.1 mg/kg are recommended for infusions of 1 and 2 mg/kg/day, respectively, in order to reach targeted plasma levels almost immediately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetoclopramideAntiemeticsDog DiseasesVomitingAnimalsDogsInfusions, IntravenousGastroesophageal RefluxDose-Response Relationship, DrugInjections, Intravenous

Substanzen

MetoclopramideAntiemetics

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Facultad de Ciencias Agropecuarias, IRNASUS CONICET - Universidad Católica de Córdoba, Córdoba, Argentina.
  • Comparative Biomedical Sciences, The Royal Veterinary College, London, UK.
  • Clinical Services and Sciences, The Royal Veterinary College, London, UK.

ORCID-Profile: M Martin-Flores, A M Lorenzutti, L Pelligand

Zitieren

APA

Martin-Flores, M., Lorenzutti, A. M., & Pelligand, L. (2026). Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling. Journal of Small Animal Practice, 67(11), 1071-1074. https://doi.org/10.1111/jsap.70144

Vancouver

Martin-Flores M, Lorenzutti AM, Pelligand L. Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling. Journal of Small Animal Practice. 2026;67(11):1071-1074. doi:10.1111/jsap.70144

BibTeX
@article{MartinFlores2026,
  author = {Martin-Flores, M and Lorenzutti, A M and Pelligand, L},
  title = {Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling},
  journal = {Journal of Small Animal Practice},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {1071--1074},
  doi = {10.1111/jsap.70144}
}
Kostenlos starten →